Prognozy (mln)
| Okres | 2028-03-31 | 2029-03-31 | 2030-03-31 | 2031-03-31 | 2032-03-31 |
| Przychód (średnia) | 17,799.00 | 8,449.00 | 8,972.29 | 9,869.52 | 9,869.52 |
| Przychód Δ r/r | 0.00% | -52.53% | 6.19% | 10.00% | 0.00% |
| Przychód (min) | 17,799.00 | 8,449.00 | 8,972.29 | 9,869.52 | 9,869.52 |
| Przychód (max) | 17,799.00 | 8,449.00 | 8,972.29 | 9,869.52 | 9,869.52 |
| EBITDA (średnia) | 2,462.87 | 1,169.10 | 1,241.51 | 1,365.66 | 1,365.66 |
| EBIT (średnia) | 1,771.23 | 840.78 | 892.86 | 982.14 | 982.14 |
| EBIT % | 9.95% | 9.95% | 9.95% | 9.95% | 9.95% |
| Zysk netto % | 12.10% | 5.65% | 5.33% | 5.38% | 5.38% |
| EPS (średnia) | 23.50 | 5.21 | 5.22 | 5.79 | 5.79 |
| Liczba analityków (Przychody) | 1 | 1 | 1 | 1 | 1 |
| Liczba analityków (EPS) | 1 | 1 | 1 | 1 | 1 |
| symbol | INDRAMEDCO.NS | INDRAMEDCO.NS | INDRAMEDCO.NS | INDRAMEDCO.NS | INDRAMEDCO.NS |